Eric U. Yee, MD

Eric U. Yee, MD
Associate Professor
Director of Surgical Pathology
University Hospital Level 2
Stony Brook Medicine
Stony Brook, NY 11794-7025

Tel: 631-444-9024
Fax: 631-444-3419

Clinical Practice:
Dr. Yee is board certified in Anatomic and Clinical Pathology.


Institution and Location

Degree Year Field of Study
University of Colorado Denver & Health Sciences Center, Denver, CO M.D. 2003-07    
Immunology & Molecular Genetics, University of California at Los Angeles, Los Angeles, CA B.S. 1999-2003 Microbiology






Postdoctoral Training:

2011-12  Fellowship, Gastrointestinal & Hepatobiliary Pathology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA
2009-10  Chief Resident, Clinical Pathology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA
2007-11 Residency, Anatomic & Clinical Pathology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA





Awards and Honors:

2020 Reviewer Advisory Panel, Annals of Diagnostic Pathology
2020 Ad hoc Reviewer, Archives of Pathology & Laboratory Medicine
2019-Present  Assistant Editor, American Journal of Clinical Pathology
2019 Ad hoc Reviewer, American Journal of Clinical Pathology
2009 Resident Representative Leadership Award, American Society for Clinical 







Positions and Employment:

2020-Present Associate Professor, Director of Surgical Pathology, Department of Pathology, Stony Brook University, Stony Brook, NY
2019-Present Consultant, PathAI, Boston, MA
2018-20 Director, Gastrointestinal Pathology Subspecialty Service, Department of Pathology, University of Arkansas for Medical Services, Little Rock, AR
2017-20 Assistant Professor, Department of Pathology, University of Arkansas for Medical Services, Little Rock, AR
2016-17 Co-Director, Surgical Pathology, Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK
2016-17 Director, Immunohistochemistry Laboratory, Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK
2016-17 Director, Quality Assurance for Anatomic Pathology, Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK
2016-17 Assistant Professor, Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK
2016-17 Staff Pathologist, Department of Pathology, University of Oklahoma Medical System, Oklahoma City, OK
2014-16 Associate Medical Director, Immunohistochemistry Loboratory, Department of Pathology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA
2012-16 Instructor in Pathology, Harvard Medical School, Boston, MA
2012-16 Staff Pathologist, Department of Pathology, Beth Israel Deaconess Medical Center















Peer Reviewed Articles:

1)  Jeong W, Schneider J, Hansen A, Lee M, TurneyS, Faulkner-Jones B, Hecht J, Najarian R, Yee E, Lichtman J, Pfister, H. "A Collaborative Digital Pathology System for Multi-Touch Mobile and Desktop Computing Platforms." Computer Graphics Forum. Vol. 32. Issue 6. Sept 2013; pp 227-242. [DOI: 10.1111/cgf.12137]

2)  SawhneyM,DicksteinJ,LeClair J, Lembo C, Yee E. "Polyps with high grade dysplasia and early adenocarcinoma are more likely to be sessile in the proximal colon." Colorectal Disease. Vol. 17. Issue 8. Aug 2015; pp 682-88. [PMID: 25619115]

3)  Sahi K, Lee K, Moss A, Yee E, Allard F, Brook A, Mortele K. "MR Enterography of the Ileoanal Pouch: Descriptive Radiologic Analysis With Endoscopic and Pathologic Correlation." American Journal of Roentgenology. Vol. 205. Issue 5. Nov 2015; pp W478-84. [PMID: 26496569]

4)  Bhasin M, Ndebele K, Bucur O, Yee E, Otu H, Plati J, Bullock A, Gu X, Castan,E, Zhang P, Najarian R, Muraru M, Miksad R, Kohsravi-Far R, Liberman T. "Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier." Oncotarget. Vol. 7. Issue 17. Apr 2016; pp 23263-81. [PMID: 26993610]

5)  Zenlea T, Yee E, Rosenberg L, Boyle M, Nanda K, Wolf J, Falchuk K, Cheifetz A, Goldsmith J, Moss A. "Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study." American Journal of Gastroenterology. Vol. 111. Issue 5. May 2016; pp 685-90. [PMID: 26977756]

6)  Liberal R, Grant C, Ma Y, Csizmadia E, Jiang Z, Heneghan M, Yee E, Mieli-Vergani G, Vergani D, Robson S, Longhi M. "CD39 Mediated Regulation of Th17-Cell Effector Function is Impaired in Juvenile Autoimmune Liver Disease." Journal of Autoimmunity. Vol. 72. Aug 2016; pp 102-12. [PMID: 27210814]

7)  LeeJ, Moraes-Vieira P, Castoldi A, Aryal P, Yee E, Vickers C, Parnas O, Donaldson C, Saghatelian A, Kahn B. "Branched fatty acid esters of hydroxy fatty acids (FAHFAs) protect against colitis by regulating the gut innate and adaptive immune systems." J Biol Chem. Vol. 291. Issue 42. Oct 2016; pp 22207-222. [PMID: 27573241]

8)  Zhang L, Pleskow D, Turzhitsky V, Yee E, Berzin T, Sawhney M, Shinagare S, Vitkin E, Zakharov Y, Khan U, Wang F, Goldsmith J ,Goldberg S, Chuttani R, Itzkan I, Qiu L, Perelman L. "Light scattering spectroscopy identifies the malignant potential of pancreatic cysts during endoscopy." Nature Biomedical Engineering. Mar 2017; Epub.[PMID: 29057146]

9)  Hoda R, Sanyal S, Abraham J, Everett J, Hundemer G, Yee E, Lauwers G, Tolkoff-Rubin N, Misdraji, J. "Lanthanum deposition from oral lanthanum carbonate in the upper gastrointestinal tract. "Histopathology. Vol. 70. Issue 7. Jun 2017; pp 1072-78. [PMID: 28134986]

10)  Feldbrügge L, Moss A, Yee E, Csizmadia E, Mitsuhashi S, Longhi M, Sandhu B, Stephan H, Wu Y, Cheifetz A, Müller C, Sévigny J, Robson S, Jiang Z. "Expression of ecto-nucleoside triphosphate diphosphohydrolases-2 and -3 in the enteric nervous system impacts inflammation in experimental colitis and Crohn's disease." J Crohns Colitis. Vol. 11. Issue 9. Sep 2017; pp 1113-23. [PMID: 28472257]
11)  Feldbrügge L, Jiang Z, Csizmadia E, Mitsuhashi S, Tran S, Yee E, Rothweiler S, Vaid K,
Sévigny J, Schmelzle M, Popov Y, Robson S. "Distinct roles of ecto-nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in liver regeneration and fibrosis." Purinergic Signal. Vol. 14. Issue 1. Mar 2018; pp 37-46. [PMID: 29134411]

12)  Qiu L, Chuttani, R, Pleskow D, Turzhitsky V, Khan U, Zakharov Y, Zhang L, Berzin T, Yee E, Sawhney M, Li Y, Vitkin E, Goldsmith J, Itzkan I, Perelman L. "Multispectral light scattering endoscopic imaging of esophageal precancer." Light: Science & Applications. Vol. 7. Apr 2018. pp 17174. [PMID: 30839534]

13)  LewisS, Besa C, Wagner M, Jhaveri K, Kihira S, Zhu H, Sadoughi N, Fischer S, Srivastava A, Yee E, Mortele K, Babb J, Thung S, Taouli B. "Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging." Eur Radiol. Vol. 28. Issue 5. May 2018; pp 2047-57. [PMID: 29234913]

14)  Liu M, Yang J, Zhang Y, Zhou Z, Cui X, Zhang L, Fung K, Zheng W, Allard F, Yee E, Ding K, Wu H, Liang Z ,Zheng L, Fernandez-Zapico M, Li Y ,Bronze M, Morris K, Postier R, Houchen C, Yang J ,L iM. "ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and claudin-1 through a ZEB1-Dependent Transcriptional Mechanism." Clin Cancer Res. Vol. 24. No. 13. Jul 2018; pp 3186-96 [PMID: 29615456]

15)  Allard F, Goldsmith J, Ayata G, Challies T, Najarian R, Nasser I ,Wang H, Yee E. "Intraobserverand Interobserver Variability in the Assessment of Dysplasia in Ampullary Mucosal Biopsies." Am J Surg Pathol. Vol. 42. No. 8. Aug 2018; pp 1095-1100.[PMID: 29738360]

16)  JiangZ, Tapper E, Kim M, Connelly M, Krawczyk S, Yee E, Herman M, Mukamal K, Lai M. "Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease." J Clin Gastroenterol. Vol. 52. Issue 5.May/Jun2018; pp 444-51. [PMID: 28362682]

17)  Ewing L, McGill M, Yee E, Quick C, Skinner C, Kennon-McGill S, Clemens M, Vazquez J, McCullough S, Williams D, Kutanzi K, Walker L, ElSohly M, James L, Gurley B, Koturbash I. "Paradoxical Patterns of Sinusoidal Obstruction Syndrome-Like Liver Injury in Aged Female CD-1 Mice Triggered by Cannabidiol-Rich Cannabis Extract and Acetaminophen Co-Administration." Molecules. 2019 Jun 17;24(12). pii: E2256.[PMID: 31212965]

18)  Osterman M, Gordon I, Davis E, Ciorba M, Glover S, Abraham B, Khan F, Guo X, Yee E, Allard F, Claggett B, Shen B, Liu J. "Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn's Disease."Inflamm Bowel Dis. 2019 Sep 25. pii: izz222. [Epub ahead of print][PMID: 31553433]

19)  Vazquez J, Clemens M, Allard F, Yee E, Kennon-McGill S, Mackintosh S, Jaeschke H, Hambuchen M, McGill M." Identification of Serum Biomarkers to Distinguish Hazardous and Benign Aminotransferase Elevations." Toxicol Sci. Vol. 173. Issue 2. Feb 2020; pp 244-54[PMID: 31651977]. Featured Tox Spotlight Article.
20)  Skinner C, Nookaew I, Ewing L, Wongsurawat T, Jenjaroenpun P, Quick C, Yee E, Piccolo BD, ElSohly MA, Walker LA, Gurley BJ, Koturbash I. Potential probiotic or trigger of gut inflammation –the Janus-faced nature of Cannabidiol-rich cannabis extract. J Diet Suppl (in press)